Onitor Track is an advanced biometric, data-driven program which aids in weight loss. Onitor Track combines a personalized weight loss and nutrition program with a dual-positioned wearable via an app.
The research team claimed that the effectiveness of drugs depends on the time of administration on a personalized level. Their goal was to identify the biomarkers in blood to characterize the ‘internal time’ of an individual.
NHS Digital and NHS England together have devised a free NHS app to book GP appointments in a swifter and user-friendly way. This novel NHS app will be launched in December 2018, allowing patients to access their health records in a safe and secure manner.
This research study was conducted on 100,000 participants including both HIV and non-HIV patients, aged around 48 years on an average. The results were published in the Journal of the American Heart Association where the participants with higher levels of bilirubin had 76% risk for cardiovascular diseases as same as the group with the lower bilirubin levels.
In a major breakthrough in the medical field, one of the world’s most dreadful viruses could possibly treat deadly brain tumors (glioblastoma). The survival chance turned out to be better than expected especially for patients who were administered the genetically modified poliovirus.
Telemedicine services are gaining entry into Japanese hospitals. Royal Philips recently announced its deal with Showa University in Japan in order to launch the first telemedicine intensive care program (eICU) at Showa Koto Toyosu Hospital and Showa University Hospital. This program will reduce mortality rates and increase savings as well as case volume.
A report was issued by the World Health Organization (WHO) recently that the number of people receiving hepatitis C cures was increased from 1 million in 2015 to 1.5 million in 2016. Previously, only a small number of countries took part in hepatitis C treatments.
Johnson & Johnson has once again won in its appeals campaign against talcum powder verdicts. Last year, the company had secured two reversals. In this year, the Missouri Court of Appeals reversed another verdict in Gloria Ristesund’s case worth $55 million, where the court lacked jurisdiction.
The premarket approval of Pulmonx’s Zephyr Endobronchial Valve to treat severe emphysema has green-lighted by the FDA. Zephyr is a pencil eraser-sized device delivered directly to the lung in a minimally invasive procedure. After the successful delivery, the device stops air from entering diseased parts of the lung during breathing. This mechanism prevents the air from getting trapped by damaged alveoli and stops the breathing difficulties.
This app uses a smartphone camera, computer vision algorithms and machine learning tools to assess bilirubin levels in the white part of the eye named sclera since jaundice is considered as one of the earliest symptoms of pancreatic cancer. The eyes and the skin become yellow colored due to the accumulation of bilirubin in the blood caused by jaundice.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.